|
|
Other links at Articles > HIV/AIDS |
| 2. |
Genetics Influence Antiretroviral Therapy-Associated Lipoatrophy
|
|
|
HIV-infected patients who possess a common mutation in the hemochromatosis gene (HFE), and possibly those who inherit mitochondrial DNA haplogroup J, may be protected from the development of lipoatrophy associated with antiretroviral therapy (ART), research suggests. Reuters Health Information
|
| 3. |
Integrase Inhibitor Raises Questions About HIV Kinetics
|
|
|
Raltegravir, a novel integrase inhibitor, enhances both phases of HIV decay, researchers report. This "challenges the current understanding of HIV-1 turnover and compartmentalization," they note in the November 12th issue of AIDS. Reuters Health Information
|
|
|